Park Jong-Sup | Division of Gynecologic Oncology, Department of Obsterics and Gynecology, Catholic University Medica
スポンサーリンク
概要
- 同名の論文著者
- Division of Gynecologic Oncology, Department of Obsterics and Gynecology, Catholic University Medicaの論文著者
関連著者
-
Kim Chan-joo
Division Of Gynecologic Oncology Department Of Obstetrics And Gynecology Catholic University Medical
-
Park Jong-Sup
Division of Gynecologic Oncology, Department of Obsterics and Gynecology, Catholic University Medica
-
Park Jong-sup
Division Of Gynecologic Oncology Department Of Obstetrics And Gynecology Catholic University Medical
-
Yim Eun-kyoung
Division Of Gynecologic Oncology Department Of Obstetrics And Gynecology Catholic University Medical
-
Bae Jeong-hoon
Division Of Gynecologic Oncology Department Of Obstetrics And Gynecology Catholic University Medical
-
Namkoong Seong-Eun
Division of Gynecologic Oncology, Department of Obsterics and Gynecology, Catholic University Medica
-
Namkoong Seong-eun
Division Of Gynecologic Oncology Department Of Obstetrics And Gynecology Catholic University Medical
-
Han Chan-hee
Division Of Gynecologic Oncology Department Of Obstetrics & Gynecology The Catholic University O
-
Lee Keun-ho
Department Of Obstetrics & Gynecology Uijeongbu St. Mary Hospital The Catholic University Of Kor
-
Kim Chan-joo
Department Of Obstetrics & Gynecology Uijeongbu St. Mary Hospital The Catholic University Of Kor
-
Park Jong-sup
Department Of Obstetrics & Gynecology Uijeongbu St. Mary Hospital The Catholic University Of Kor
-
Lee Keun-Ho
Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, The Catholic university of
-
Park Tae-Chul
Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, The Catholic university of
-
Park Tae-chul
Department Of Obstetrics & Gynecology Uijeongbu St. Mary Hospital The Catholic University Of Kor
著作論文
- P-IS-29 TACC3 is a novel target of paclitaxel; Its implication in paclitaxel-mediated tumor therapy(Oncology 8,Group 95,International Session)
- P-IS-7 Novel interaction between HPV E6 and BARD1 (BRCA1-associated ring domain 1) and its biologic roles(Oncology 2,Group 89,International Session)
- P-IS-24 Clinical outcome of staging surgery with or without bilateral salpingo-oophorectomy in clinical stage I-II endometrial cancer patients(Oncology 6,Group 93,International Session)